Jiangsu Bioperfectus Tech Co., Ltd.

Country/Region: China     State/Province: Jiangsu

Main Products: In Vitro Diagnostic

Company Introduction
Jiangsu BioPerfectus tech Co., Ltd. is located in China Medical City located at Tai Zhou in Jiang Su Province which is the only national medical high-tech park in China. Our company was founded by Shanghai BioPerfectus technologies Co. Ltd., CID Group(Shanghai) Investment Management Consulting Co., Ltd. and Beijing Ke Kang Tai Biotechnology Co. Ltd. Investments. The company has two GMP production workshops (nucleic acid and protein), is the development, production, sales in one of the bio-tech innovative enterprises. The company has multiplex fluorescence quantitative PCR, microarray, enzyme chemistry, and modern biology etc technology platform to engage in product development, production and sales, such as in infectious diseases, genetic diseases, food safety and tumor areas. We have successfully developed the infectious pathogen detection, the female reproductive tract micro flora detection, cancer screening and other dozens of products, so many products have received a certificate of registration. Meanwhile, the company is also equipped with an advanced REAL TIME PCR instruments, fusion AllGlo probes, LNA technology, HRM and other technology to provide quality technical services for universities, research institutions of Science. We advocate quality, efficiency, fairness and impartiality as our core culture, and make every effort to provide customers with the high-standard products and perfect service.
Company Overview

Business Type: Exporter, Services

Year Established: 2010

Employees: 5 - 10 People

Plant Area: 50,000-100,000 square meters

Business Information

Main Markets: South America 11% Africa 9% Eastern Asia 11% Domestic Market 8% North America 9% Eastern Europe 12% Southern Europe 8% Mid East 11% Northern Europe 11% Oceania 10%

Trade Capacity: FOB, CIF, DDU

Contract Manufacturing: OEM Service Offered ,Design Service Offered

Nearest Port: Taizhou

Trade & Financial Information

Annual Revenue: Above US$100 Million

Total Revenue: Above US$100 Million

Export Revenue: US$10 Million - US$50 Million

Annual Output: US$5 Million - US$10 Million

Registered Capital: Above US$100 Million

Export Percentage: 91% - 100%

Payment Modes: USD, EUR, HKD

Lead Time: 9 days

Import/Export Mode: Have Own Export License

Product Showcase
In Vitro Diagnostic

CL-Link > Health & Medicines in China Health & Medicines in Jiangsu Other Medical Equipment in China Other Medical Equipment in Jiangsu